ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,970.84
-1.11%
US Tech 100
20,897.20
-1.35%
다우존스 지수
42,992.21
-0.77%
Bitcoin
93,758.07
0.25%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Oncodesign Precision Medicine SA (ALOPM) 시세

Oncodesign Precision Medicine SA

Oncodesign Precision Medicine SA (ALOPM)

EU
0.77
0.01
(1.32%)
마감 30 12월 1:30AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
0.77
매수가
0.762
매도가
0.77
거래량
3,703
0.762 일간 변동폭 0.82
0.73 52주 범위 2.06
market_cap
14.007M
전일 종가
0.76
개장가
0.82
최근 거래 시간
1000
@
0.77
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
9,307
발행 주식
18,190,878
배당수익률
-
주가수익률
-1.73
주당순이익(EPS)
-0.44
매출
1.08M
순이익
-8.09M

Oncodesign Precision Medicine SA 정보

섹터
Electromedical Apparatus
산업
Electromedical Apparatus
웹사이트
www.oncodesign.com
본부
Dijon, Cote-d'or, Fra
설립됨
-
Oncodesign Precision Medicine SA is listed in the Electromedical Apparatus sector of the 유로넥스트 (Euronext) with ticker ALOPM. The last closing price for Oncodesign Precision Med... was 0.76 €. Over the last year, Oncodesign Precision Med... shares have traded in a share price range of 0.73 € to 2.06 €.

Oncodesign Precision Med... currently has 18,190,878 shares in issue. The market capitalisation of Oncodesign Precision Med... is 13.83 € million. Oncodesign Precision Med... has a price to earnings ratio (PE ratio) of -1.73.

ALOPM 최신 뉴스

추가 뉴스

Oncodesign Precision Medicine reprend les droits sur son programme OPM-201 auprès de Servier après une phase I volontaires sains positive

Reprise par OPM de l’intégralité des droits du programme OPM-201 et du portefeuille de brevets associé Confirmation de l’innocuité de la molécule chez les volontaires sains Regulatory News:...

20 12월 2024
Business Wire

OPM détaille les résultats finaux de son étude de phase 1 avec OPM-101, inhibiteur de la cible RIPK2, avec des données de sécurité solides sans toxicité cardiaque, ouvrant la voie au lancement de la phase 1b/2a

Finalisation du rapport d’étude de l’essai de phase 1 de l’OPM-101 contrôlé par placebo en double aveugle chez 104 volontaires sains (VS) ayant reçu OPM-101 L’analyse des ECG enregistrés sur 24h...

23 10월 2024
Business Wire

OPM Announces Poster Presentation on OPM-101, a RIPK2 Kinase Inhibitor, in Healthy Volunteers at UEG Week 2024 Conference

Presentation by Professor Laurent Peyrin-Biroulet (M.D., PhD Professor of Gastroenterology at CHRU of Nancy) and Bruno Robin (PharmD, Head of OPM Clinical Development) of safety, pharmacokinetic...

15 10월 2024
Business Wire

OPM annonce ses résultats du premier semestre 2024 et fait le point sur ses développements cliniques, et sa situation financière

OPM-101 conclut positivement sa Phase 1 volontaires sains permettant de prévoir le démarrage d'un essai clinique de Phase 1b/2a, fin 2024 début 2025 OPM-201, licenciée à Servier dans la maladie...

26 9월 2024
Business Wire

OPM Announces Positive Results of Its Phase 1 in Healthy Volunteers with OPM-101: Strong Target Engagement With Excellent Safety Profile

End of double-blind, placebo-controlled phase 1 trial with OPM-101: 104 healthy volunteers (VS) participated in this trial designed to assess the safety of OPM-101 in humans Very good safety...

17 7월 2024
Business Wire
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.028-3.508771929820.7980.890.73331350.8454885DE
4-0.29-27.3584905661.061.070.73114940.94096986DE
12-0.355-31.55555555561.1251.350.7393071.10858969DE
26-0.24-23.76237623761.011.350.73102091.10032802DE
52-1.04-57.45856353591.812.060.73110401.24977525DE
156-0.22-22.22222222220.992.390.73105641.46010195DE
260-0.22-22.22222222220.992.390.73105641.46010195DE

ALOPM - Frequently Asked Questions (FAQ)

What is the current Oncodesign Precision Med... share price?
The current share price of Oncodesign Precision Med... is 0.77 €
How many Oncodesign Precision Med... shares are in issue?
Oncodesign Precision Med... has 18,190,878 shares in issue
What is the market cap of Oncodesign Precision Med...?
The market capitalisation of Oncodesign Precision Med... is EUR 13.83M
What is the 1 year trading range for Oncodesign Precision Med... share price?
Oncodesign Precision Med... has traded in the range of 0.73 € to 2.06 € during the past year
What is the PE ratio of Oncodesign Precision Med...?
The price to earnings ratio of Oncodesign Precision Med... is -1.73
What is the cash to sales ratio of Oncodesign Precision Med...?
The cash to sales ratio of Oncodesign Precision Med... is 12.98
What is the reporting currency for Oncodesign Precision Med...?
Oncodesign Precision Med... reports financial results in EUR
What is the latest annual turnover for Oncodesign Precision Med...?
The latest annual turnover of Oncodesign Precision Med... is EUR 1.08M
What is the latest annual profit for Oncodesign Precision Med...?
The latest annual profit of Oncodesign Precision Med... is EUR -8.09M
What is the registered address of Oncodesign Precision Med...?
The registered address for Oncodesign Precision Med... is 18 RUE JEAN MAZEN, DIJON, COTE-D'OR, 21000
What is the Oncodesign Precision Med... website address?
The website address for Oncodesign Precision Med... is www.oncodesign.com
Which industry sector does Oncodesign Precision Med... operate in?
Oncodesign Precision Med... operates in the ELECTROMEDICAL APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
15.95 €
(2,146.48%)
2.17k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.87 €
(40.22%)
2.43M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
110.23k
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
ALEUPEuroplasma
0.0413 €
(-14.67%)
3.93M
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ATOAtos SE
0.0027 €
(17.39%)
3.02B
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
NEOENNeoen SA
39.83 €
(0.73%)
81.42M
BCPBanco Comercial Portugues SA
0.4602 €
(2.04%)
75.06M
ALHPIHopium SA
0.005 €
(0.00%)
19.56M

토론

전체 피드 보기
marcis marcis 4 분 전
Mexedia news
Shareholders meeting convened after the close Friday Dec. 27

Approved of the release of 2024 Financial’s April 29 2025

As already known the 1st half 2024 vs 1st half 2023 revenue and gross profits are down.
The reason is because they are movi
RDAR
3331 3331 5 분 전
BIEL: #4 Breakout Board, NEWS - 911 Market Maker final trade Friday, Golden Cross Blue Sky Breakout!
PENNY PIRATE PENNY PIRATE 6 분 전
JonDoe1 ... Clearly You Missed the Point that there is, and it will be put to Good Use! 😇
AABB
3331 3331 6 분 전
BIEL: #4 Breakout Board, NEWS - 911 Market Maker final trade Friday, Golden Cross Blue Sky Breakout!
Doc logic Doc logic 7 분 전
martyDg,

You are correct about speculation because so many details are left out. On the other hand you and we all know that Merck was given an opportunity at best look into the DCVax platform by way of Dr. Duffy’s presence with NWBO during the development period for the SAP and BMY w
BMY NWBO
OnlyCredibleFactsMatter OnlyCredibleFactsMatter 7 분 전
2 Walmart reviews
👍️
5 out of 5 stars review
Verified Purchase

Nov 14, 2024
Awesome!
Kristine
I could go anywhere with my device and laptop. No cell phone required!
Sold by:Tri Cascade, Inc.
Delivered by:Walmart
I
SRMX
NinjaOasis53 NinjaOasis53 11 분 전
Looking forward to it >> As I said I doubled up between.004-5 but also in at .0015
HLLK
Viking61 Viking61 12 분 전
Wasn’t that imbellish that had access to? I can’t remember for sure.
gitreal gitreal 13 분 전
If they had invested that $52 million in cash in blue chip stocks, they would now have $60 or 70 million. Tough to invest imaginary money.
AABB
3331 3331 14 분 전
Pointing out that Apple has over 15 billion shares - to a bunch of bashers that claim companies with billions of shares are trash (but can't explain why) - is relevant. Twisting it the way you do is not, and demonstrates your complete inability to come up with an intelligent post. I haven't seen a
BIEL
tuzedaze tuzedaze 16 분 전
David Fiderer was right about Whalen a long time ago…. https://www.fidererongses.com/blog/params/post/1043010/gse-critics-ignore-credit-market-data
FNMA
jbog jbog 17 분 전
We have to keep in mind that Enanta is not following the norm when it comes to small bio research. By far, the majority of bio's of similar size would partner prior to patient trials so they could share the cost and risk. For Enta to develop a drug and then hoping a partner comes along is not good
ddls ddls 17 분 전
WOW! BIEL's scammers are out today.😎
BIEL
crazy horse 0 crazy horse 0 18 분 전
Did you know this about a wolf pack?

https://x.com/Mindset_Machine/status/1873422311241736563
G-ManSoFla G-ManSoFla 18 분 전
A pumper posting another pumper's pump posts? Say that three times fast. By the time you say it will $TNXP be down another 10%?
TNXP
Stinger2014 Stinger2014 19 분 전
OC doesn’t answer it just makes noise.
CGAC
theorysuit theorysuit 19 분 전
Paid NWBO Retail here gloss over the fact that NWBO paid for LP's CDMOs. That is unreal. It is of no concern, nor do they care....LMFAO at the paid pump crew.
NWBO
TightCoil TightCoil 19 분 전
What? Are you getting a raise from
$1.99/hr. to $2.27/hr. for picking up
shopping carts at Krogers.? You deserve it,
Lil Feller
FNMA
th6565 th6565 20 분 전
OT : Unless US wins the global battle for semiconductor supremacy, US future economy won’t be smooth sailing on top of high tariffs being proposed.

People in 2025 will be wiped out financially if I keep listening to so many experts’ predictions on the air news.
LWLG
Boris the Spider Boris the Spider 20 분 전
LG and LP.

The Perps are so arrogant and delusional that they truly believe that after 16 yrs of wackamole they are untouchable and immune. Here's where they are wrong. If we are not starting to see some payment flow very soon or at least an announcement of forthcoming payouts they c
COOP
Stinger2014 Stinger2014 20 분 전
Bingo! Too easy.
CGAC
Acme Investments Acme Investments 21 분 전
👇 Why aren't you sailing ⛵ your Yacht in some tropical climate?? Let the shareholders worry about the fate of our ticker!! Big Tony is waiting for the Don to get comfortable and then Boom!!
USEI
worthylion worthylion 21 분 전
CCEL Nyberg family filed Form 13G last week showing they have sold all of their 600,000 shares which explains the recent selling pressure and higher volume. Share price now seems poised for a rally leading up to their next .25 dividend at the end of February. 

최근 히스토리

EU
ALOPM
Oncodesign Precision Med...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유